Methylprednisolone Acetate Injectable Suspension Recalled for Temperature Abuse During Manufacturing
McKesson Medical-Surgical is recalling Methylprednisolone Acetate Injectable Suspension nationwide due to temperature abuse during manufacturing that may affect product quality. Healthcare providers should verify receipt.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This FDA Class II recall addresses a manufacturing process deviation (temperature abuse) affecting injectable medication with nationwide distribution. Although no illnesses or injuries have been reported, injectable drugs with temperature-related process deviations pose a risk to product sterility and efficacy.
Plain-English summary
McKesson Medical-Surgical is recalling Methylprednisolone Acetate Injectable Suspension USP, 80 mg/mL, manufactured by Teva Pharma USA. The product is available in single-dose vials (NDC 0703-0051-01) and 25-count boxes (NDC 0703-0051-04).
The recall is due to cGMP deviations involving temperature abuse during manufacturing, which may affect product quality, potency, or integrity.
The product was distributed nationwide to healthcare facilities. Affected quantities include 1088 cartons of single-dose vials and 63 cartons of 25-vial boxes. Specific lot numbers have not been identified; McKesson has sent notification letters to affected customers with their specific shipment dates and dates of potentially impacted product.
Healthcare providers who received this product should verify receipt and consult with McKesson regarding appropriate measures. As of the recall notification, no illnesses or injuries have been reported associated with this product.
The recalled product
- Product
- MethyLPREDNISolone Acetate Injectable Suspension USP, 80 mg/mL, packaged in a) 1 mL single dose vial (NDC 0703-0051-01) b) 25-count box (NDC 0703-0051-04), Rx only, MFG: Teva Pharma USA
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 130 recalled by Mckesson Medical-Surgical Inc. Corporate Office under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 130 products in this recall →Related recalls
Same manufacturer · Mckesson Medical-Surgical Inc. Corporate Office
See all →- ModerateStrep A test kits recalled after shipment to unlicensed purchasing customers
FDA (Devices) · 2025-08-27
- ModerateProlia prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateEvenity prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateBenlysta vials recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateAbbott Diagnostics ARC Carbon Dioxide Calibrator Cold Chain Storage Issue
FDA (Devices) · 2025-06-04
Same hazard · temperature abuse
See all →- ModerateGemcitabine Injection Recalled Due to Temperature Storage Abuse
FDA (Drugs) · 2026-07-08
- ModerateGarland Fresh peeled garlic recalled over Clostridium botulinum contamination risk
FDA (Food) · 2026-05-13
- ModerateChristopher Ranch peeled garlic recalled over Clostridium botulinum contamination risk
FDA (Food) · 2026-05-13
- SevereCrab Cakes Sold to Food Service Recalled for Botulism Risk
FDA (Food) · 2026-04-15
- CriticalUDENYCA syringes recalled after cartons were stored at room temperature
FDA (Drugs) · 2026-02-18